EL
45
2
CTAS
64
2
XYL
43
-4
MRK
66
3
VLO
33
-5
BBY
55
-2
SWN
30
-12
WY
27
-7
AIV
60
3
AA
38
3
GOOGL
67
3
FTI
76
2
EXC
47
2
FOX
30
2
SIG
47
-3
RIG
28
2
HSIC
44
4
ECL
84
14
MLM
63
2
SLB
48
2
EL
45
2
CTAS
64
2
XYL
43
-4
MRK
66
3
VLO
33
-5
BBY
55
-2
SWN
30
-12
WY
27
-7
AIV
60
3
AA
38
3
GOOGL
67
3
FTI
76
2
EXC
47
2
FOX
30
2
SIG
47
-3
RIG
28
2
HSIC
44
4
ECL
84
14
MLM
63
2
SLB
48
2
Financhill
Back

Cassava Sciences Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
28

SAVA
Cassava Sciences

Last Price:
20.01
Seasonality Move:
1.68%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
28
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy, Sell or Hold?

  • The current Cassava Sciences [SAVA] share price is $20.02. The Score for SAVA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • SAVA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SAVA Stock Price Chart

What is Cassava Sciences's stock price today?

  • The Cassava Sciences share price today is $20.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SAVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.53 Sell
Relative Strength Index (14 RSI): 45.41 Sell
Chaikin Money Flow: 121540 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.63 - 22.09) Sell
Bollinger Bands (100): (20.03 - 23.41) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

SAVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.61 Buy
20-day SMA: 20.51 Sell
50-day SMA: 21.26 Sell
200-day SMA: 21.56 Sell
8-day EMA: 19.86 Buy
20-day EMA: 20.34 Sell
50-day EMA: 21.03 Sell
200-day EMA: 22.15 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Cassava Sciences Earnings Growth & SAVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and an increase next year of $1.37 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Cassava Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):